SCI Abstract

search
+
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study
The study aimed to evaluate whether postoperative TACE improves outcomes in patients with resected Dual-phenotype hepatoce...
The Prognostic Value of Lymphocyte-to-Monocyte Ratio for Long-Term Survival After TACE in Intermediate-to-Advanced Hepatocellular Carcinoma
The Prognostic Value of Lymphocyte-to-Monocyte Ratio for Long-Term Survival After TACE in Intermediate-to-Advanced Hepatocellular Carcinoma
Investigating the predictive value of the LMR for long-term survival in patients with intermediate-to-advanced HCC undergo...
Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy
Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy
this study aims to analyze the predictive role of early-phase PIVKA-II level changes in patients with advanced HCC undergo...
MRI-Based Deep Learning and Radiomics Nomogram for Predicting Hepatocellular Carcinoma Recurrence Within Six Months After Thermal Ablation
MRI-Based Deep Learning and Radiomics Nomogram for Predicting Hepatocellular Carcinoma Recurrence Within Six Months After Thermal Ablation
Developing a MRI-based deep learning-radiomics-clinical nomogram for predicting early recurrence of HCC within six months ...
Establishing a Survival Time Prediction Model for Patients with Hepatocellular Carcinoma After TACE Based on CT Radiomics: A Multi-Center Study
Establishing a Survival Time Prediction Model for Patients with Hepatocellular Carcinoma After TACE Based on CT Radiomics: A Multi-Center Study
Constructing a prognostic model for overall survival in hepatocellular carcinoma patients using radiomic features from non...
Prognostic Value of Clinical and CT Features in Camrelizumab Plus Apatinib Treatment for Unresectable Hepatocellular Carcinoma
Prognostic Value of Clinical and CT Features in Camrelizumab Plus Apatinib Treatment for Unresectable Hepatocellular Carcinoma
This study aimed to evaluate the prognostic value of clinical and CT features in Camrelizumab plus Apatinib treatment for ...
Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis
Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis
This study aimed to evaluate the prognostic value of CK19 expression in patients undergoing targeted therapy and immunothe...
Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
The study aimed to explore the interplay between hypoxia- and anoikis-related lncRNAs and the prognosis of HCC patients.
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication
we proposed a risk prediction model for the risk of HCC in cured CHC patients with and without advanced liver fibrosis.
Prognostic Signature of NETs-Related Genes in Hepatocellular Carcinoma Based on Bulk and Single-Cell Transcriptomics
Prognostic Signature of NETs-Related Genes in Hepatocellular Carcinoma Based on Bulk and Single-Cell Transcriptomics
we integrated single-cell RNA sequencing data with TCGA resources to identify key NETs-related genes associated with HCC p...
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Evaluating the predictive value of another hepatocellular carcinoma tumor marker, protein induced by vitamin K absence/ant...
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
This study compares ICI-based therapy with TACE in a real-world postoperative setting and to assess whether extended ICI t...
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE
Evaluate the Assessment for Retreatment with TACE score in predicting survival after trans-arterial chemoembolization in h...
The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma
The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma
This study screened 12 members of the let-7 family & their related lncRNAs. We then selected targets that have predict...
Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Evaluating clinical efficacy of postoperative adjuvant transarterial chemoembolization in cytokeratin 19-positive hepatoce...
Spontaneous Rupture of Hepatocellular Carcinoma: Pathogenesis, Clinical Management, Prognostic Factors, and Future Directions
Spontaneous Rupture of Hepatocellular Carcinoma: Pathogenesis, Clinical Management, Prognostic Factors, and Future Directions
By integrating available data and highlighting unresolved questions, we hope to guide clinical practice and inform the des...
Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway
Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway
In the study, we provided novel insights into the mechanism of CMSS1 in HCC progression.
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
Nuclear medicine holds potential for identifying patients who are likely to benefit from targeted and immunotherapy.
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model
This study shows that preoperative hepatic steatosis is an independent risk factor for postoperative recurrence in HBV-rel...
ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma
ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma
we developed and validated the ANT Score, a novel prognostic model that integrates nutrition, inflammation, and tumor burd...
Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma
Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma
The potential role and prognostic value of APOE in hepatocellular carcinoma (HCC) using bioinformatics and multiplex fluor...
Outcomes and Prognostic Factors in Cirrhotic Patients with Acute Variceal Bleeding and Hepatocellular Carcinoma: A Nested Case–Control Study
Outcomes and Prognostic Factors in Cirrhotic Patients with Acute Variceal Bleeding and Hepatocellular Carcinoma: A Nested Case–Control Study
To assess the outcomes of acute variceal bleeding in cirrhotic patients with HCC, compared to a matched cohort of cirrhoti...
Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients
Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients
Developing and validating a machine learning-based prognostic model to predict survival outcomes in patients with HBV-rela...
Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis
Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis
In this study, we utilized two databases, TCGA and our hospital data, to assess the impact of COIL on the prognosis of HCC...
Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma
Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma
Exploring the value of intravoxel incoherent motion (IVIM) sequences in predicting intra-tumoral tertiary lymphoid structures
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective
Taking molecular subtypes and HCC biomarkers into consideration may improve survival in patients when making individualize...
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma
Identifying cell clusters that significantly contribute to Hepatocellular Carcinoma development and their underlying mecha...
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
this study evaluates changes in SMI after TACE-MTAs-ICIs treatment, and to analyze the association of reversal of SMI with...
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Evaluating the efficacy and safety of TACE combined with HAIC plus lenvatinib for intermediate-stage HCC beyond up-to-seve...
A Case of DEB-TACE Combined with Anlotinib for Treatment of Liver Metastasis from Retroperitoneal Leiomyosarcoma
A Case of DEB-TACE Combined with Anlotinib for Treatment of Liver Metastasis from Retroperitoneal Leiomyosarcoma
Reporting a case with multiple liver metastases from retroperitoneal leiomyosarcoma, confirmed by postoperative pathology,...
Load More
format_indent_increase